Latest filing published 17 Aug 2020 for CorMedix Inc., €35k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +21.5%Entry US$4.84 · Close at T+365 US$5.88
- -60.3%Entry US$9.06 · Close at T+365 US$3.60
- -61.0%Entry US$8.30 · Close at T+365 US$3.24
- -5.9%Entry US$6.65 · Close at T+365 US$6.26
- +122.8%Entry US$2.85 · Close at T+365 US$6.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jr. John L. Armstrong: trading record in brief
Jr. John L. Armstrong appears in our data through filings on CorMedix Inc. shares, published by SEC (Form 4). The record holds 9 filings, for trades running from 12 December 2017 to 14 August 2020.
The open-market record is one-sided, with 7 purchases worth €482k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 option exercises. In 2020 alone, the filings show 3 purchases and no sales.
The median purchase comes to €34k. 7 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 7 purchases show a median change of +19.6%, with the price up in 57% of them. Past outcomes like these are no guarantee of what comes next.
Most recently, on 17 August 2020, the filings show an open-market purchase worth €35k in CorMedix Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jr. John L. Armstrong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$4.1635.8% of flowCommon StockSEC:0001213900-20-022579:0Canonical exit: 12 Nov 2020 (T+90)
- 7,500 shares@ US$4.1426.7% of flowCommon StockSEC:0001213900-20-022579:1Canonical exit: 12 Nov 2020 (T+90)
- 10,000 shares@ US$4.3537.5% of flowCommon StockSEC:0001213900-20-022579:2Canonical exit: 12 Nov 2020 (T+90)
- 5,000 shares@ US$7.737.2% of flowCommon StockSEC:0001654954-19-003466:0Canonical exit: 24 Jun 2019 (T+90)
- 15,000 shares@ US$1.694.7% of flowCommon StockSEC:0001654954-19-003244:0Canonical exit: 23 Jun 2019 (T+90)
- 18,029 shares0Common StockSEC:0001654954-19-000079:0
- 250,000 shares@ US$1.4567.3% of flowCommon StockSEC:0001654954-18-013406:0Canonical exit: 27 Feb 2019 (T+90)
- 18,028 shares0Common StockSEC:0001654954-18-002933:0
- 20,833 shares@ US$0.481.8% of flowCommon StockSEC:0001654954-17-011649:0Canonical exit: 12 Mar 2018 (T+90)
9 of 9 declarations
